<- Back to digest

JSES - 2026-10-01 - Journal Article; Multicenter Study

Assessment of virulence traits in Cutibacterium acnes from shoulder periprosthetic joint infections.

Frappa N, Listopadzki TR, Lutnick E, Feng L, Crane JK, Duquin TR

retrospective cohortLOE IIIn = 87 C. acnes isolates (2 institutions)N/A

Topics

shoulder elbowbasic science
PMID: 42069126DOI: 10.1016/j.jse.2026.04.044View on PubMed ->

Key Takeaway

Hemolysis and aerotolerance were present in >50% of C. acnes isolates from shoulder PJI evaluations but failed to distinguish definite from nondefinite infection, while clindamycin resistance rates varied from 6.9% to 12.6% depending on whether CLSI or EUCAST breakpoints were applied.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This multicenter study evaluated whether in vitro virulence traits (hemolysis, aerotolerance, growth rate) and antimicrobial susceptibility profiles of 87 C. acnes isolates could differentiate true shoulder PJI from contamination using 2018 ICM consensus criteria as the reference standard. Only 12.6% of cases met definite infection criteria, with 48.3% classified as probable. Neither hemolysis nor aerotolerance was associated with infection classification on univariate or multivariable analysis, and clindamycin resistance rates differed by interpretive standard (EUCAST 12.6% vs. CLSI 6.9%).

Key Limitation

The reference standard (2018 ICM criteria) is itself poorly validated for low-virulence, slow-growing organisms like C. acnes, creating circular diagnostic uncertainty that limits the interpretability of all phenotype-to-infection associations reported.

Original Abstract

BACKGROUND

Cutibacterium acnes is the most common pathogen in shoulder periprosthetic joint infection (PJI) but remains difficult to distinguish from contamination due to its low virulence and presence as a skin commensal. Diagnostic ambiguity and variable antibiotic resistance further complicate management.

METHODS

We analyzed 87 C acnes isolates from patients undergoing evaluation for shoulder PJI across 2 institutions. Isolates were obtained from intraoperative cultures and stored for subsequent analysis. Hemolysis, aerotolerance, and growth rate were assessed in vitro. Antimicrobial susceptibility to 5 antibiotics was determined using minimum inhibitory concentration testing, with interpretive breakpoints defined by both the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. Infection status was classified per the 2018 International Consensus Meeting criteria into definite, probable, possible, or unlikely categories. Associations between phenotypic traits and infection classification were assessed using univariate and multivariable statistical models.

RESULTS

Only 12.6% (n = 11) of cases met criteria for definite infection, while the majority (48.3%) were classified as probable. Hemolysis and aerotolerance were observed in 51.7% and 54.0% of isolates, respectively, and were strongly associated with one another (P < .001); however, neither phenotype was associated with infection classification in univariate or multivariable analysis. Clindamycin resistance was observed in a minority of isolates but varied by standard, with 12.6% classified as resistant by EUCAST and 6.9% as non-susceptible by CLSI. No isolates were resistant to vancomycin; doxycycline and rifampin minimum inhibitory concentrations were uniformly low.

CONCLUSION

Neither hemolysis nor aerotolerance reliably distinguished definite PJI from nondefinite cases, limiting their diagnostic utility in this cohort. Clindamycin resistance was uncommon, yet classification differed based on the interpretive criteria used (CLSI vs. EUCAST), highlighting potential inconsistencies in clinical reporting. Moreover, the predominance of "probable" infections illustrates a critical limitation of current consensus criteria, which may both underestimate true infection burden in indolent presentations and overestimate infection due to reliance on positive cultures in the absence of clear clinical findings. More precise diagnostic frameworks may help address current classification challenges and better support clinical decision-making in shoulder arthroplasty.